Acutaas Chemicals Limited has informed the Exchange about Investor Presentation
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Acutaas Chemicals (formerly Ami Organics) released a corporate presentation ahead of investor meets. The company reported FY26 revenue of ₹13,394 Mn with PAT of ₹3,564 Mn and PAT margin of 26.6%, up significantly from ₹10,069 Mn revenue and 15.9% PAT margin in FY25. The specialty chemicals maker operates across four segments: Pharmaceutical Intermediates (87.7% of revenue, ₹11,741 Mn), Commodity Chemicals (11.2%, ₹1,495 Mn), Semiconductor Chemicals (1.2%, ₹157 Mn), and Battery Chemicals (pre-revenue with 10+ products in pipeline). The company claims 50-90% global market share in key pharmaceutical intermediates and is India’s only manufacturer of photoresist chemicals and first electrolyte additives manufacturer. Total capex of ₹1,000+ Cr is planned from FY23 to FY30 across pharma, battery, semiconductor, and R&D. The company has 5 manufacturing facilities and ~1,000 employees.
Strong margin expansion (PAT margin jumped from 15.9% to 26.6%) and revenue growth indicate improving profitability. The market cap stands at ₹20,948 Cr with shares trading at ₹2,559. Battery and semiconductor chemicals remain early-stage investments with no commercial revenue yet.